Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 2 patents

Readers on

mendeley: 11 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT

Grant EP-3616720-B1

European Patent Office

REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1…

Application EP-3439653-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.